Australia Morphine Market (2025-2031) | Segmentation, Growth, Share, Companies, Outlook, Trends, Value, Competitive Landscape, Industry, Forecast, Size & Revenue, Analysis

Market Forecast By Type (Oral Tablets, Injection, Capsule, Others), By Application (Anesthesia, Cough Suppressant, Diarrhea Suppressant) And Competitive Landscape
Product Code: ETC6185584 Publication Date: Sep 2024 Updated Date: Apr 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Australia Morphine Market Overview

Morphine remains a critical component in Australia`s pain management and palliative care protocols. The market is regulated and monitored closely due to the opioid crisis. While demand remains strong in hospital settings, strict prescription controls and alternative pain relief therapies may impact long-term growth.

Trends of the market

The morphine market in Australia is shaped by its critical role in palliative care, surgical recovery, and chronic pain management. With tighter opioid regulations, there is a growing emphasis on controlled distribution and alternative pain therapies. Pharmaceutical companies are exploring abuse-deterrent formulations and slow-release delivery systems to align with national opioid safety strategies.

Challenges of the market

The morphine market in Australia is constrained by strict opioid regulations and growing public concern over opioid addiction. Despite being essential for pain management, morphine usage is under heavy scrutiny, limiting its prescription and distribution. Regulatory bodies have introduced measures to curb overuse, which affects market expansion. Healthcare providers are increasingly cautious, and there is a push toward alternative pain therapies, which further pressures the traditional morphine market.

Investment opportunities in the Market

There are steady investment opportunities in Australia’s regulated morphine market, especially in pharmaceutical manufacturing and supply chain management. As pain management remains a core medical need, investment in slow-release or abuse-deterrent formulations can offer a competitive edge. Moreover, specialized logistics and storage services for controlled substances represent another area of potential growth for investors in pharmaceutical infrastructure.

Government Policy of the market

The Australian government regulates the use of morphine through the TGA, which has implemented strict guidelines for prescribing and distributing opioids. The government’s policies aim to prevent opioid misuse and overprescription, following a growing national concern over opioid addiction. The National Pharmaceutical Drug Misuse Strategy and various state-based programs seek to curb misuse and promote the use of alternative pain management therapies. While morphine is still an essential drug for pain management, government policies are pushing for the development and adoption of non-opioid treatments, which may limit the growth of the morphine market in Australia.

Key Highlights of the Report:

  • Australia Morphine Market Outlook
  • Market Size of Australia Morphine Market, 2024
  • Forecast of Australia Morphine Market, 2031
  • Historical Data and Forecast of Australia Morphine Revenues & Volume for the Period 2021- 2031
  • Australia Morphine Market Trend Evolution
  • Australia Morphine Market Drivers and Challenges
  • Australia Morphine Price Trends
  • Australia Morphine Porter's Five Forces
  • Australia Morphine Industry Life Cycle
  • Historical Data and Forecast of Australia Morphine Market Revenues & Volume By Type for the Period 2021- 2031
  • Historical Data and Forecast of Australia Morphine Market Revenues & Volume By Oral Tablets for the Period 2021- 2031
  • Historical Data and Forecast of Australia Morphine Market Revenues & Volume By Injection for the Period 2021- 2031
  • Historical Data and Forecast of Australia Morphine Market Revenues & Volume By Capsule for the Period 2021- 2031
  • Historical Data and Forecast of Australia Morphine Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Australia Morphine Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of Australia Morphine Market Revenues & Volume By Anesthesia for the Period 2021- 2031
  • Historical Data and Forecast of Australia Morphine Market Revenues & Volume By Cough Suppressant for the Period 2021- 2031
  • Historical Data and Forecast of Australia Morphine Market Revenues & Volume By Diarrhea Suppressant for the Period 2021- 2031
  • Australia Morphine Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Application
  • Australia Morphine Top Companies Market Share
  • Australia Morphine Competitive Benchmarking By Technical and Operational Parameters
  • Australia Morphine Company Profiles
  • Australia Morphine Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Australia Morphine Market Overview

3.1 Australia Country Macro Economic Indicators

3.2 Australia Morphine Market Revenues & Volume, 2021 & 2031F

3.3 Australia Morphine Market - Industry Life Cycle

3.4 Australia Morphine Market - Porter's Five Forces

3.5 Australia Morphine Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Australia Morphine Market Revenues & Volume Share, By Application, 2021 & 2031F

4 Australia Morphine Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Australia Morphine Market Trends

6 Australia Morphine Market, By Types

6.1 Australia Morphine Market, By Type

6.1.1 Overview and Analysis

6.1.2 Australia Morphine Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Australia Morphine Market Revenues & Volume, By Oral Tablets, 2021- 2031F

6.1.4 Australia Morphine Market Revenues & Volume, By Injection, 2021- 2031F

6.1.5 Australia Morphine Market Revenues & Volume, By Capsule, 2021- 2031F

6.1.6 Australia Morphine Market Revenues & Volume, By Others, 2021- 2031F

6.2 Australia Morphine Market, By Application

6.2.1 Overview and Analysis

6.2.2 Australia Morphine Market Revenues & Volume, By Anesthesia, 2021- 2031F

6.2.3 Australia Morphine Market Revenues & Volume, By Cough Suppressant, 2021- 2031F

6.2.4 Australia Morphine Market Revenues & Volume, By Diarrhea Suppressant, 2021- 2031F

7 Australia Morphine Market Import-Export Trade Statistics

7.1 Australia Morphine Market Export to Major Countries

7.2 Australia Morphine Market Imports from Major Countries

8 Australia Morphine Market Key Performance Indicators

9 Australia Morphine Market - Opportunity Assessment

9.1 Australia Morphine Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Australia Morphine Market Opportunity Assessment, By Application, 2021 & 2031F

10 Australia Morphine Market - Competitive Landscape

10.1 Australia Morphine Market Revenue Share, By Companies, 2024

10.2 Australia Morphine Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All